SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,206,000 | +3.4% | 107,645 | +1.5% | 0.00% | 0.0% |
| Q2 2017 | $1,166,000 | +17.7% | 106,035 | +4.8% | 0.00% | +50.0% |
| Q1 2017 | $991,000 | +30.4% | 101,172 | +43.8% | 0.00% | 0.0% |
| Q4 2016 | $760,000 | +13.3% | 70,368 | +7.5% | 0.00% | 0.0% |
| Q3 2016 | $671,000 | -17.8% | 65,438 | +4.7% | 0.00% | 0.0% |
| Q2 2016 | $816,000 | +43.9% | 62,508 | +21.3% | 0.00% | 0.0% |
| Q1 2016 | $567,000 | +19.9% | 51,543 | +0.2% | 0.00% | 0.0% |
| Q4 2015 | $473,000 | +44.2% | 51,463 | +9.0% | 0.00% | +100.0% |
| Q3 2015 | $328,000 | -26.0% | 47,228 | +4.7% | 0.00% | 0.0% |
| Q2 2015 | $443,000 | -19.2% | 45,092 | -27.0% | 0.00% | -50.0% |
| Q1 2015 | $548,000 | +14.9% | 61,807 | +13.6% | 0.00% | +100.0% |
| Q4 2014 | $477,000 | +33.6% | 54,407 | +4.9% | 0.00% | 0.0% |
| Q3 2014 | $357,000 | +29.8% | 51,862 | -0.7% | 0.00% | 0.0% |
| Q2 2014 | $275,000 | +15.5% | 52,212 | -0.0% | 0.00% | 0.0% |
| Q1 2014 | $238,000 | -14.1% | 52,232 | -4.8% | 0.00% | 0.0% |
| Q4 2013 | $277,000 | -2.8% | 54,862 | -2.3% | 0.00% | 0.0% |
| Q3 2013 | $285,000 | +1.4% | 56,162 | -0.9% | 0.00% | 0.0% |
| Q2 2013 | $281,000 | – | 56,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|